My work sits where reproductive medicine, research rigour, and digital health converge — shaping products and communications that are clinically grounded, deeply evidence-led, and built to genuinely serve women.
Women's health data exists.
The problem is — nobody acts on it.
Symptoms are dismissed. Data is collected but never interpreted. Science exists but doesn't reach patients at the right moment. Most solutions aren't built with clinical insight at the core — it's added as an afterthought.
My work sits at exactly this point of breakdown — where evidence meets product, and science finally reaches the people it was always meant to serve.
That gap is where I do my best work.
I'm a medical doctor with dual master's-level training in Reproductive Science and Women's Health (UCL) and Reproductive and Developmental Medicine (University of Sheffield) — currently based in London, advising globally.
My background spans clinical practice, public health research, and product advisory — from IVF clinics to a national research body to FemTech platforms shaping the next generation of women's health tools. Each role has sharpened the same instinct: pairing scientific rigour with real-world relevance.
I'm particularly drawn to the space between "normal" and "pathological" — where complaints get minimised, signs get missed, or good evidence never quite makes it into the room with the patient. And I believe that gap isn't unique to any one country. It's global.
Four active advisory roles across reproductive health and FemTech innovation — each selected for alignment with my clinical expertise and research focus.
"I've deeply enjoyed working with Ashlesha. She brings a thoughtful, thorough, and balanced approach to all her work while effectively managing timelines. Her understanding and expertise in women's health are valuable assets, and she has greatly improved the accuracy and overall quality of every piece of content she's touched."
Background & Clinical Experience
A PRISMA-based systematic review examining fertility awareness, knowledge, attitudes, and behaviours across South Asian populations — with implications that extend far beyond any single geography.
The findings reveal not only the depth of the knowledge gap — but the structural reasons it persists. The aim is to translate this evidence into frameworks for education, clinical practice, and policy that can drive meaningful change.
Collaborate on this researchFertility awareness isn't broken in one country. The same patterns of dismissal, silence, and misunderstanding appear across geographies — different cultural contexts, the same systemic failures.
The ambition: a body of evidence so robust that these gaps become impossible to ignore — and a network of collaborators committed to closing them, globally.
Research scope expanding across
Structured advisory engagements for organisations at every stage — from pre-product concept through to clinical validation, investor positioning, and scale. Each engagement is shaped around what the work actually requires.
Clinical oversight and strategic guidance for digital health platforms — ensuring safety, accuracy, and real-world clinical relevance throughout development and communications.
Translating complex reproductive science into clear, clinically accurate content for patients, platforms, and stakeholders — without sacrificing rigour.
Evidence-based educational materials for patients, clinicians, and health-tech users — designed to improve awareness, trust, and informed decision-making.
Literature reviews, evidence synthesis, and research frameworks to guide product development, publications, and clinical positioning with robust scientific backing.
Working with early-stage and scaling startups to shape clinically sound, user-centred reproductive health products — from concept through validation and launch.
Medically accurate documents, protocols, and content aligned with clinical standards and regulatory expectations for healthcare and digital health contexts.
Clinically trained, not just academically informedOver four years of hands-on clinical practice in IVF and reproductive medicine — not theoretical knowledge applied after the fact, but direct patient experience that informs every advisory decision.
Bridges patients, clinicians, and product teamsThe ability to move fluently between clinical evidence, patient experience, and product logic — simultaneously, not sequentially. Most advisors speak one language. This work requires three.
Specialised in women's health gapsA focused specialism in the zone where clinical evidence fails to reach practice — where symptoms are minimised, data is misread, and good science stalls before it helps anyone. This is where most products fall short, and where the most important work remains to be done.
A genuinely global perspectiveFrom ICMR in India to dual postgraduate training in the UK, to poster presentations at ESHRE and GLOW 2026 — the scope of this work has always been international. Women's reproductive health is a global issue that demands a global lens.
I work with founders, clinical teams, and organisations building at the intersection of women's health and digital innovation — from early-stage startups to established platforms seeking scientific rigour and clinical credibility.
Each engagement is scoped individually. The right structure — whether a focused project, an ongoing advisory retainer, or a combination — depends on where you are and what the work demands.
Engagements typically include medical content review, clinical advisory retainers, evidence strategy, and scientific communications — structured around your stage and objectives. Rates provided on enquiry.
Tell me about your project and I'll respond within 2–3 business days.
Short-form thinking on the gaps, opportunities, and systemic challenges in reproductive health — for founders, clinicians, and anyone building in this space.
Clinical expertise is too often brought in at the end — to validate rather than to shape. The result is products that are technically functional but clinically insufficient.
Coming soon →A PRISMA-based systematic review of South Asian populations reveals structural gaps in how women are educated about their fertility — and why those gaps persist across generations and geographies.
Coming soon →A PRISMA review of South Asian populations reveals systemic gaps in how women are educated about fertility. The same pattern shows up far beyond South Asia.
Coming soon →The most common failure in women's health innovation is not ambition — it's the absence of clinical insight at the point where it matters most. If you're building something in this space, early advisory input is the difference between a product that resonates and one that misses.